Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Subgroup Analyses of Progression-Free Survival from the Phase 3 Octans and Alcyone Studies in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Bortezomib, Melphalan, and Prednisone with or without Daratumumabopen access

Authors
Fu, WeijunBang, Soo-MeeHuang, HonghuiKim, KihyunLi, WeiAn, GangLee, Je-JungCai, ZhenJin, JieWang, YafeiChim, Chor SangOtero, Paula RodriguezDimopoulos, Meletios A.Fujisaki, TomoakiLee, Jae HoonWroblewski, SusanBorgsten, FredrikCarson, RobinLiu, RuiZhao, ManWu, TingtingChen, XiCui, CanchanHou, JianWang, Jianxiang
Issue Date
Nov-2023
Publisher
AMER SOC HEMATOLOGY
Citation
BLOOD, v.142
Journal Title
BLOOD
Volume
142
URI
https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/91893
DOI
10.1182/blood-2023-180809
ISSN
0006-4971
1528-0020
Files in This Item
There are no files associated with this item.
Appears in
Collections
ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Lee, Jae Hoon photo

Lee, Jae Hoon
College of Medicine (Department of Medicine)
Read more

Altmetrics

Total Views & Downloads

BROWSE